News

Bausch Health’s Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)

LAVAL, QC / ACCESSWIRE / September 29, 2023 / Bausch + Lomb Corporation ("Bausch + Lomb") (NYSE/TSX:BLCO), a subsidiary of…

1 year ago

Hologic to Expand Outreach During Breast Cancer Awareness Month

Launches Global Partnership With Know Your Lemons, Will Ring Nasdaq Opening Bell for 17th TimeMARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #bcam--Hologic, Inc. (Nasdaq:…

1 year ago

Whittier Street Health Center to Host Hispanic Heritage Month Celebration on October 13th

The theme for this year's annual event is "Prioritizing Health: A Prescription for Prosperity, Power and Progress!"BOSTON, MA / ACCESSWIRE…

1 year ago

Curated Mental Health Drives Mental Health Awareness Through September Yellow Campaign

NEW YORK, NY / ACCESSWIRE / September 29, 2023 / In 2022, a staggering 49,449 Americans lost their lives to…

1 year ago

BioStem Technologies: CMS Decision a “Win For Patients”

POMPANO BEACH, FL / ACCESSWIRE / September 29, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company…

1 year ago

Infinx Healthcare Recognized as a Sample Vendor for Intelligent Prior Authorization for Second Year in a Row in the Gartner Hype Cycle for U.S. Healthcare Payers, 2023

Gartner Hype Cycle Recognizes Infinx Healthcare as a Sample Vendor for Intelligent Prior AuthorizationNEW YORK, NY / ACCESSWIRE / September…

1 year ago

Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)

TORONTO, ON / ACCESSWIRE / September 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical…

1 year ago

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid…

1 year ago

FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal Syndrome

DENVER, Sept. 29, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions…

1 year ago